These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 6616505)

  • 1. Cholecystokinin inhibits pancreatic and hepatic carcinogenesis.
    Johnson FE; LaRegina MC; Martin SA; Bashiti HM
    Cancer Detect Prev; 1983; 6(3):389-402. PubMed ID: 6616505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic carcinogenesis-enhancement by cholecystokinin in the hamster-nitrosamine model.
    Howatson AG; Carter DC
    Br J Cancer; 1985 Jan; 51(1):107-14. PubMed ID: 3966964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapeutic treatment of pancreatic cancer based on injection of pcDNA3.1/CCK plasmid with xenogeneic homologous cholecystokinin.
    Lu Y; Bai JG; Wang HH
    Exp Oncol; 2006 Jun; 28(2):136-40. PubMed ID: 16837905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of synthetic protease inhibitor on the oncogenesis of pancreatic cancer in hamsters: study on pancreatic endocrine cells and free radicals].
    Asano N; Manabe T; Yoshimura T; Imanishi K; Tobe T
    Nihon Geka Hokan; 1991 Nov; 60(6):424-34. PubMed ID: 1820014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of four retinoids in N-nitrosobis(2-oxopropyl)amine-treated hamsters.
    Longnecker DS; Kuhlmann ET; Curphey TJ
    Cancer Res; 1983 Jul; 43(7):3226-30. PubMed ID: 6850632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of growth of azaserine-induced putative preneoplastic lesions in rat pancreas is mediated specifically by way of cholecystokinin-A receptors.
    Povoski SP; Zhou W; Longnecker DS; Roebuck BD; Bell RH
    Cancer Res; 1993 Sep; 53(17):3925-9. PubMed ID: 8358719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of laparoscopic biopsy of pancreatic lymph nodes on lipid peroxidation using helium and carbon dioxide in BOP-induced pancreatic cancer in hamsters.
    Wenger FA; Kilian M; Proske JM; Guski H; Schimke I; Jacobi CA
    Surg Endosc; 2001 Oct; 15(10):1150-5. PubMed ID: 11727090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes of A, B and D cells in Langerhans islets in pancreatic cancers of hamsters.
    Asano N; Manabe T; Imanishi K; Tobe T
    Nihon Geka Hokan; 1991 Jul; 60(4):233-42. PubMed ID: 1776915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of protocatechuic acid on the post-initiation phase of hamster pancreatic carcinogenesis induced by N-nitrosobis(2-oxopropyl)amine.
    Nakamura H; Nishikawa A; Furukawa F; Kasahara K; Miyauchi M; Son HY; Hirose M
    Anticancer Res; 2000; 20(5B):3423-7. PubMed ID: 11131643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does alpha-linolenic acid in combination with linoleic acid influence liver metastasis and hepatic lipid peroxidation in BOP-induced pancreatic cancer in Syrian hamsters?
    Wenger FA; Kilian M; Jacobi CA; Schimke I; Guski H; Müller JM
    Prostaglandins Leukot Essent Fatty Acids; 2000 Jun; 62(6):329-34. PubMed ID: 10913224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orotic acid enhancement of preneoplastic and neoplastic lesions induced in the pancreas and liver of hamsters by N-nitroso(2-hydroxypropyl) (2-oxopropyl)amine.
    Kokkinakis DM; Albores-Saavedra J
    Cancer Res; 1994 Oct; 54(20):5324-32. PubMed ID: 7923160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmentation of carcinogenesis by N-nitrosobis(2-oxopropyl)amine administered during S phase of the cell cycle in regenerating hamster pancreas.
    Scarpelli DG; Rao MS; Subbarao V
    Cancer Res; 1983 Feb; 43(2):611-6. PubMed ID: 6848182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of chronic endogenous hypergastrinaemia on pancreatic growth and carcinogenesis in the hamster.
    Chu M; Kullman E; Rehfeld JF; Borch K
    Gut; 1997 Apr; 40(4):536-40. PubMed ID: 9176085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinogenicity of N-nitrosomethyl(2-oxopropyl)amine in Syrian hamsters.
    Pour P; Gingell R; Langenbach R; Nagel D; Grandjean C; Lawson T; Salmasi S
    Cancer Res; 1980 Oct; 40(10):3585-90. PubMed ID: 7438045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bile-reflux into the pancreatic ducts is associated with the development of intraductal papillary carcinoma in hamsters.
    Adachi T; Tajima Y; Kuroki T; Mishima T; Kitasato A; Fukuda K; Tsutsumi R; Kanematsu T
    J Surg Res; 2006 Nov; 136(1):106-11. PubMed ID: 16863651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of involvement of metallothionein expression in pancreatic carcinogenesis by N-nitrosobis (2-oxopropyl) amine in Syrian hamsters.
    Minami T; Sakita Y; Okazaki Y; Tsutsumi M; Konishi Y
    Cell Mol Biol (Noisy-le-grand); 2000 Mar; 46(2):445-50. PubMed ID: 10774932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinase inhibitor RO 28-2653 decreases liver metastasis by reduction of MMP-2 and MMP-9 concentration in BOP-induced ductal pancreatic cancer in Syrian Hamsters: inhibition of matrix metalloproteinases in pancreatic cancer.
    Kilian M; Gregor JI; Heukamp I; Hanel M; Ahlgrimm M; Schimke I; Kristiansen G; Ommer A; Walz MK; Jacobi CA; Wenger FA
    Prostaglandins Leukot Essent Fatty Acids; 2006 Dec; 75(6):429-34. PubMed ID: 17034997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of pancreatic cancer induction in hamsters by metformin.
    Schneider MB; Matsuzaki H; Haorah J; Ulrich A; Standop J; Ding XZ; Adrian TE; Pour PM
    Gastroenterology; 2001 Apr; 120(5):1263-70. PubMed ID: 11266389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of inducible nitric oxide synthase (iNOS) in N-nitrosobis(2-oxopropyl)amine-induced hamster pancreatic carcinogenesis and prevention of cancer development by ONO-1714, an iNOS inhibitor.
    Takahashi M; Kitahashi T; Ishigamori R; Mutoh M; Komiya M; Sato H; Kamanaka Y; Naka M; Maruyama T; Sugimura T; Wakabayashi K
    Carcinogenesis; 2008 Aug; 29(8):1608-13. PubMed ID: 18567618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms for the pancreatic oncogenic effects of the peroxisome proliferator Wyeth-14,643.
    Obourn JD; Frame SR; Bell RH; Longnecker DS; Elliott GS; Cook JC
    Toxicol Appl Pharmacol; 1997 Aug; 145(2):425-36. PubMed ID: 9266817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.